Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension

Heart

Volumn 91, Issue 5, 2005, Pages 624-629

  Poulsen, Steen H ^a   Andersen, N H ^a   Heickendorff, L ^a   Mogensen, C E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE LONGITUDINAL STRAIN; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; MALE; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLE;

CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FIBROSIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIUM; PEPTIDE FRAGMENTS; PROCOLLAGEN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 17644397407     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.029702     Document Type: Article

References (26)

1. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
2. Devereux RB, Roman MJ, Liu JE, et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the strong heart study. Am J Cardiol 2000;86:1090-6.
3. O'Connor CM, Gattis WA, Shaw L, et al. Clinical characteristics and long-term outcome of patients with heart failure and preserved systolic function. Am J Cardiol 2000;86:863-7.
4. Jalil JE, Doering CW, Janicki JS, et al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64:1041-5.
5. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388-93.
6. Conrad CH, Brooks WW, Hayes JA, et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rats. Circulation 1995;91:161-70.
7. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107-15.
8. Kozakova M, Galetta F, Gregorini L, et al. Coronary vasodilator capacity and epicardial vessel remodelling in physiological and hypertensive hypertrophy. Hypertension 2000;36:343-9.
9. Schwartzkopff B, Brehm M, Mundhenke M, et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000;36:220-5.
10. Diez J, Panizo A, Gil MJ, et al. Serum markers of collagen type I metabolism in spontaneously hypertensive rats. Circulation 1996;93:1026-32.
11. Weber KT. Monitoring tissue repair and fibrosis from a distance. Circulation 1997;96:2488-92.
12. Querejeta R, Varo N, López B, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000;101:1729-35.
13. Lopez B, Querejeta R, Varo N, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioprotective ability of antihypertensive treatment in hypertensive patients. Circulation 2001;104:286-91.
14. Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105:2512-7.
15. Pan C, Hoffman R, Kühl H, et al. Tissue tracking allows rapid and accurate visual evaluation of left ventricular function. Eur J Echocardiogr 2001;2:197-202.
16. Urheim S, Edvardsen T, Torp H, et al. Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function. Circulation 2000;102:1158-64.
17. Poulsen SH, Andersen NH, Ivarsen PI, et al. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J Am Soc Echocardiogr 2003;16:724-31.
18. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
19. Møller JE, Søndergaard E, Poulsen SH, et al. Pseudonormal and restrictive filling patterns predict left ventricular dilation and cardiac death after a first myocardial infarction: a serial color M-mode Doppler echocardiographic study. J Am Coll Cardiol 2000;36:1841-6.
20. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984;4:1222-30.
21. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. J Am Coll Cardiol 1997;30:8-18.
22. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-75.
23. Gonzalez A, Lopez B, Quereta R, et al. Regulation of myocardial fibrillar collagen by angiotensin II: a role in hypertensive heart disease? J Mol Cell Cardiol 2002;34:1585-93.
24. Vinereanu D, Florescu N, Sculthorpe N, et al. Differentiation between pathologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001;88:53-8.
25. Edvardsen T, Gerber BL, Garot J, et al. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: salidation against three-dimensional tagged magnetic resonance imaging. Circulation 2002;106:50-6.
26. Pontremoli R, Ravera M, Bezante GP, et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999;17:993-1000.